eCite Digital Repository
Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review
Citation
Noor, S and Mohammad, T and Farhat, J and Bilgrami, AL and Eapen, MS and Sohal, SS and Yadav, DK and Hassan, MI, Mechanistic insights into the role of serum-glucocorticoid kinase 1 in diabetic nephropathy: A systematic review, International Journal of Biological Macromolecules, 193, (Pt A) pp. 562-573. ISSN 0141-8130 (2021) [Refereed Article]
Copyright Statement
© 2021 Elsevier B.V. All rights reserved.
DOI: doi:10.1016/j.ijbiomac.2021.10.165
Abstract
Aberrant expression of serum-glucocorticoid kinase 1 (SGK1) contributes to the pathogenesis of multiple disorders, including diabetes, hypertension, obesity, fibrosis, and metabolic syndrome. SGK1 variant is expressed in the presence of insulin and several growth factors, eventually modulating various ion channels, carrier proteins, and transcription factors. SGK1 also regulates the enzymatic activity of Na+ K+ATPase, glycogen synthase kinase-3, ubiquitin ligase Nedd4-2, and phosphomannose mutase impacting cell cycle regulation, neuroexcitation, and apoptosis. Ample evidence supports the crucial role of aberrant SGK1 expression in hyperglycemia-mediated secondary organ damage. Diabetic nephropathy (DN), a dreadful microvascular complication of diabetes, is the leading cause of end-stage renal failures with high morbidity and mortality rate. The complex pathogenesis of DN encompasses several influencing factors, including transcriptional factors, inflammatory markers, cytokines, epigenetic modulators, and abnormal enzymatic activities. SGK1 plays a pivotal role by controlling various physiological functions associated with the occurrence and progression of DN; therefore, targeting SGK1 may favorably influence the clinical outcome in patients with DN. This review aimed to provide mechanistic insights into SGK1 regulated DN pathogenesis and summarize the evidence supporting the therapeutic potential of SGK1 inhibition and its consequences on human health.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | diabetic nephropathy, epithelial sodium channel, hyperglycemia, renal fibrosis, serum glucocorticoid kinase, therapeutic targeting |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Cardiovascular medicine and haematology |
| Research Field: | Cardiology (incl. cardiovascular diseases) |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Diagnosis of human diseases and conditions |
| UTAS Author: | Eapen, MS (Dr Mathew Eapen) |
| UTAS Author: | Sohal, SS (Dr Sukhwinder Sohal) |
| ID Code: | 147616 |
| Year Published: | 2021 |
| Web of Science® Times Cited: | 3 |
| Deposited By: | Health Sciences |
| Deposited On: | 2021-11-10 |
| Last Modified: | 2022-08-25 |
| Downloads: | 0 |
Repository Staff Only: item control page